BDNF and cancer: Pathways including IL-2 Receptor Beta Chain in T cell Activation, Keratinocyte Differentiation, T cell receptor pathway, and Neurotrophin signaling pathway were enriched in the low-risk group [18], many of these being closely related to the occurrence and development of cancer [19] (Figure 6 and Supplementary Table 2).